Connection

David Mahvi to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications David Mahvi has written about Antineoplastic Agents.
David Mahvi
Connection Strength
0.239
Antineoplastic Agents
  1. Liver directed therapies for colorectal cancer. Cancer Chemother Biol Response Modif. 2003; 21:831-43.
    View in: PubMed
    Score: 0.125
  2. Impact of selection bias on the utilization of adjuvant therapy for pancreas adenocarcinoma. Ann Surg Oncol. 2010 Feb; 17(2):371-6.
    View in: PubMed
    Score: 0.050
  3. Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients. J Clin Oncol. 2004 Nov 15; 22(22):4463-73.
    View in: PubMed
    Score: 0.035
  4. Immunological effects of levamisole in vitro. J Immunother (1991). 1991 Oct; 10(5):297-306.
    View in: PubMed
    Score: 0.014
  5. Diagnosis and management of retroperitoneal soft-tissue sarcoma. Ann Surg. 1991 Jul; 214(1):2-10.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.